Friday, July 10, 2026

pharma · Alzheimer Disease · Pulmonary Fibrosis

Shanghai University of

Shanghai University of clinical programs — 3 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Shanghai, China, CN HQ
6 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Shanghai, China, CN
Employees
6
Programs
24
Drugs
33
Patents
0
Intelligence · Clinical Programs

Shanghai University of projects

3 ClinicalTrials.gov programs sponsored by Shanghai University of.

Shanghai University of has 3 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. GV-971

    Shanghai University of Traditional Chinese Medicine

    Alzheimer Disease

    phase 3 small molecule on hold

    1 trial
  2. JS001

    Shanghai University of Traditional Chinese Medicine

    Triple-Negative Breast Cancer

    phase 3 small molecule completed

    1 trial
  3. Sodium Thiosulfate Injection

    Shanghai University of Traditional Chinese Medicine

    Hepatoblastoma

    phase 3 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does Shanghai University of have?

3 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.